NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
-2.2%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$714M
AUM Growth
+$37.8M
(+5.6%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
22.56%
Top 10 Holdings %
Top 10 Hldgs %
80.08%
Holding
30
New
8
Increased
5
Reduced
6
Closed
1
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
+$72.6M |
| 2 |
Apple
AAPL
|
+$53M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$52.4M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$7.03M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$6.17M |
Top Sells
| 1 |
Glaukos
GKOS
|
+$23M |
| 2 |
OrthoPediatrics
KIDS
|
+$19.3M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
+$3.23M |
| 4 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
+$3.06M |
| 5 |
DERM
Dermira, Inc.
DERM
|
+$2.72M |
Sector Composition
| 1 | Healthcare | 79.61% |
| 2 | Technology | 7.43% |
| 3 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Inogen
INGN
$231M
| $237M | 33.2% |
3,549,321
+1
| +0% | +$67 |
|
|
2
Milestone Pharmaceuticals
MIST
$167M
| $72.6M | 10.17% |
+2,674,470
| New | +$72.6M |
|
|
3
Apple
AAPL
$3.47T
| $53M | 7.43% |
+1,071,152
| New | +$53M |
|
4
Cable One
CABO
$968M
| $52.7M | 7.38% |
45,000
| – | – |
|
|
MORF
5
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $52.4M | 7.35% |
+2,645,446
| New | +$52.4M |
|
6
Amicus Therapeutics
FOLD
$2.46B
| $28.9M | 4.05% |
2,317,870
+450,000
| +24% | +$5.62M |
|
|
7
Glaukos
GKOS
$4.75B
| $22.6M | 3.17% |
300,000
-305,266
| -50% | -$23M |
|
8
SI-BONE Inc
SIBN
$677M
| $18.2M | 2.54% |
892,684
-1
| -0% | -$20 |
|
|
SPNE
9
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $17.3M | 2.43% |
1,308,037
| – | – |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $16.8M | 2.36% |
570,036
+119,322
| +26% | +$3.53M |
|
11
Corvus Pharmaceuticals
CRVS
$434M
| $16.5M | 2.32% |
4,420,516
| – | – |
|
12
Akebia Therapeutics
AKBA
$782M
| $15M | 2.1% |
3,100,000
| – | – |
|
|
ETTX
13
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $14.1M | 1.97% |
2,181,843
| – | – |
|
14
Galapagos
GLPG
$2.11B
| $12.6M | 1.76% |
97,481
| – | – |
|
|
BPMC
15
DELISTED
Blueprint Medicines
BPMC
| $12.5M | 1.76% |
132,976
+65,409
| +97% | +$6.17M |
|
16
Inspire Medical Systems
INSP
$2.37B
| $10.6M | 1.49% |
175,000
| – | – |
|
|
NBRV
17
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $8.38M | 1.17% |
13,786
-5,029
| -27% | -$3.06M |
|
18
Neuronetics
STIM
$207M
| $7.29M | 1.02% |
582,798
+57,798
| +11% | +$723K |
|
19
Merus
MRUS
$5.26B
| $7.25M | 1.02% |
495,016
-7,779
| -2% | -$114K |
|
|
SILK
20
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $7.03M | 0.98% |
+145,000
| New | +$7.03M |
|
|
21
OrthoPediatrics
KIDS
$493M
| $6.27M | 0.88% |
160,742
-493,807
| -75% | -$19.3M |
|
22
Spero Therapeutics
SPRO
$107M
| $5.36M | 0.75% |
+465,983
| New | +$5.36M |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.92M | 0.69% |
119,708
-78,553
| -40% | -$3.23M |
|
|
VRNA
24
Verona Pharma
VRNA
$9.21B
| $3.78M | 0.53% |
740,740
| – | – |
|
25
Crinetics Pharmaceuticals
CRNX
$3.2B
| $3.38M | 0.47% |
135,009
| – | – |
|